© 1993 Oxford University Press
OTHER |
Pelizaeus Merzbacher disease: a frameshift deletion/insertion event in the myelin proteolipid gene
Equipe ATIPE, URA 1488 CNRS boite 14, Batiment B, 9 Quai Saint-Bernard, F-75252 Paris Cedex 1Laboratoire de Biochimie Médicale, Faculté de médecine, Clermont-Ferrand Cedex CHU Rennes, France 2Service de Génétique Pédiatrique CHU Rennes, France
* To whom correspondence should be addressed
Received December 16, 1992; Revised January 22, 1993; Accepted January 22, 1993
Among the central nervous system (CNS) dysmyelinating disorders, Pelizaeus-Merzbacher disease (PMD) has been individualized by its X-linked mode of inheritance and the existence of corresponding animal models. Mutations in the major myelin proteolipid (PLP) gene coding for PLP and its splicing variant DM20 protein, have been demonstrated in animal mutants and more recently in PMD affected patients. We have identified, in a two-generation PMD affected family, an insertion/deletion event in the exon IV of the PLP gene, leading to the synthesis of predicted truncated PLP and DM20 proteins with altered carboxyl terminal end. This is the first report of a frameshift mutation in the PLP gene in PMD.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E Fabbretti, P Edomi, C Brancolini, and C Schneider Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes & Dev., August 1, 1995; 9(15): 1846 - 1856. [Abstract] [PDF] |
||||
